S
Serge Gauthier
Researcher at McGill University
Publications - 715
Citations - 61038
Serge Gauthier is an academic researcher from McGill University. The author has contributed to research in topics: Dementia & Disease. The author has an hindex of 93, co-authored 637 publications receiving 52775 citations. Previous affiliations of Serge Gauthier include Hamamatsu University School of Medicine & La Salle University.
Papers
More filters
Journal ArticleDOI
Preclinical in vivo longitudinal assessment of KG207-M as a disease-modifying Alzheimer's disease therapeutic.
Min Su Kang,Min Su Kang,Monica Shin,Monica Shin,Julie Ottoy,Arturo Aliaga,Arturo Aliaga,Sulantha Mathotaarachchi,Sulantha Mathotaarachchi,Kely Quispialaya,Tharick A. Pascoal,Tharick A. Pascoal,D. Louis Collins,M. Mallar Chakravarty,Axel Mathieu,Åsa Sandelius,Kaj Blennow,Kaj Blennow,Henrik Zetterberg,Gassan Massarweh,Jean-Paul Soucy,A. Claudio Cuello,Serge Gauthier,Serge Gauthier,Michael Waterston,Nathan Yoganathan,Etienne Lessard,Arsalan S. Haqqani,Kerry Rennie,Danica Stanimirovic,Balu Chakravarthy,Pedro Rosa-Neto,Pedro Rosa-Neto +32 more
TL;DR: In vivo biomarker abnormalities provide measures to monitor therapeutic interventions targeting amyloid-β pathology as well as its effects on downstream processes associated with Alzheimer's diseas as mentioned in this paper, which can be used to diagnose and treat Alzheimer's disease.
Journal ArticleDOI
Clinical trials and therapy.
TL;DR: Parallel-group studies have established the efficacy of cholinesterase inhibitors in Alzheimer's disease, at least for short-term cognitive and clinical global enhancement.
Journal ArticleDOI
[p3–436]: natural history of the decline in instrumental activities of daily living prior to dementia in persons with mild cognitive impairment
TL;DR: P3-436 NATURAL HISTORY of the DECLINE in InSTRUMENTAL ACTIVities of Daily Living Prior to Dementia in People with MILD COGNITIVE IMPAIRMENT.
Journal ArticleDOI
Gantenerumab in‐depth outcomes: Results of the DIAN‐TU prevention trial of solanezumab and gantenerumab in dominantly inherited AD
Stephen Salloway,Randall J. Bateman,Andrew J. Aschenbrenner,Tammie L.S. Benzinger,David B. Clifford,Kelley Coalier,Carlos Cruchaga,Anne M. Fagan,Martin R. Farlow,Alison Goate,Brian A. Gordon,Jason Hassenstab,Clifford R. Jack,Robert A. Koeppe,Eric McDade,Susan Mills,John C. Morris,Anna Santacruz,Peter J. Snyder,Guoqiao Wang,Chengjie Xiong,B. Joy Snider,Catherine J. Mummery,Ghulam M. Surti,Didier Hannequin,David Wallon,Sarah B. Berman,James J. Lah,Ivonne Z. Jimenez-Velazquez,Erik D. Roberson,Christopher H. van Dyck,Lawrence S. Honig,Raquel Sánchez-Valle,William S. Brooks,Serge Gauthier,Colin L. Masters,Doug R. Galasko,Jared R. Brosch,Ging-Yuek Robin Hsiung,Suman Jayadev,Maïté Formaglio,Mario Masellis,Roger Clarnette,Jérémie Pariente,Bruno Dubois,Florence Pasquier,Monika Baudler,Paul Delmar,Rachelle S. Doody,Paulo Fontoura,Geoffrey A. Kerchner,Dian‐Tu Study Team +51 more